OBJECTIVE: To describe the history of SSc-associated pulmonary arterial hypertension (SSc-PAH) in patients with New York Heart Association (NYHA) functional class (FC) II dyspnoea at diagnosis. METHODS: Data at the time of diagnosis were collected and analysed retrospectively for 77 consecutive patients with SSc-PAH. RESULTS: Twelve patients (15.6%) presented with PAH and NYHA FC II dyspnoea. After a mean follow-up of 44 months, only 4 out of the 12 PAH patients remained stable in FC II, while 8 showed worsening to FC III or IV. Three patients died during the observation period; two from PAH and one from rectal cancer. Survival in patients in FC II at diagnosis was 100, 91 and 80% at 1, 2 and 3 years, respectively. CONCLUSIONS: A majority of patients with mildly symptomatic SSc-PAH in NYHA FC II at diagnosis have a severe disease with poor prognosis.
OBJECTIVE: To describe the history of SSc-associated pulmonary arterial hypertension (SSc-PAH) in patients with New York Heart Association (NYHA) functional class (FC) II dyspnoea at diagnosis. METHODS: Data at the time of diagnosis were collected and analysed retrospectively for 77 consecutive patients with SSc-PAH. RESULTS: Twelve patients (15.6%) presented with PAH and NYHA FC II dyspnoea. After a mean follow-up of 44 months, only 4 out of the 12 PAHpatients remained stable in FC II, while 8 showed worsening to FC III or IV. Three patients died during the observation period; two from PAH and one from rectal cancer. Survival in patients in FC II at diagnosis was 100, 91 and 80% at 1, 2 and 3 years, respectively. CONCLUSIONS: A majority of patients with mildly symptomatic SSc-PAH in NYHA FC II at diagnosis have a severe disease with poor prognosis.
Authors: Edward A Pankey; Matthew Epps; Bobby D Nossaman; Albert L Hyman; Philip J Kadowitz Journal: J Clin Rheumatol Musculoskelet Med Date: 2010-12-01
Authors: Monica Mukherjee; Shang-En Chung; Von Khue Ton; Ryan J Tedford; Laura K Hummers; Fredrick M Wigley; Theodore P Abraham; Ami A Shah Journal: Circ Cardiovasc Imaging Date: 2016-06-07 Impact factor: 7.792
Authors: Barbara Ruaro; Marco Confalonieri; Francesco Salton; Barbara Wade; Elisa Baratella; Pietro Geri; Paola Confalonieri; Metka Kodric; Marco Biolo; Cosimo Bruni Journal: Pharmaceuticals (Basel) Date: 2021-04-23
Authors: Vivek Thakkar; Wendy M Stevens; David Prior; Owen A Moore; Jillian Byron; Danny Liew; Karen Patterson; Pravin Hissaria; Janet Roddy; Jane Zochling; Joanne Sahhar; Peter Nash; Kathleen Tymms; David Celermajer; Eli Gabbay; Peter Youssef; Susanna M Proudman; Mandana Nikpour Journal: Arthritis Res Ther Date: 2012-06-12 Impact factor: 5.156
Authors: Monika Szturmowicz; Aneta Kacprzak; Barbara Burakowska; Marcin Kurzyna; Anna Fijałkowska; Iwona Bestry; Adam Torbicki Journal: Multidiscip Respir Med Date: 2010-12-20